Previous 10 | Next 10 |
January 23, 2020 Palm Beach, FL – January 23, 2020 – Since The Chinese authorities identified a new type of coronavirus, (novel coronavirus 2019-nCoV) from Wuhan, Hubei Province, China, which was isolated on 7 January 2020, the World Health Organization (WHO) , govern...
Neurotrope ( NTRP -0.3% ) has received commitments from certain institutional and private investors to purchase 18,000 shares of its Series D Convertible Preferred Stock at $1,000 per share yielding gross proceeds of $18M. More news on: Neurotrope, Inc., Healthcare stocks news, Stocks ...
NEW YORK , Jan. 22, 2020 /PRNewswire/ -- Neurotrope, Inc. (the "Company") (NASDAQ:NTRP) today announced that it has received commitments from institutional investors and pre-existing high net worth individuals to purchase an aggregate of $18 million of the Company's securities in a...
Gainers: Neurotrope (NASDAQ: NTRP ) +126% . More news on: Neurotrope, Inc., Genprex, Inc., Trillium Therapeutics Inc., Stocks on the move, , Read more ...
Will The Names On This List Of Penny Stocks Rally Higher This Week? One of the most important things to keep in mind about penny stocks is that investors can make massive returns from only a small investment. On the other hand, that can work against investors as well. Since these stocks gene...
Thinly traded nano cap Neurotrope ( NTRP +113.1% ) rallies on a healthy 57x surge in volume in reaction to data from a Phase 2 clinical trial evaluating lead candidate Bryostatin-1 in patients with moderately severe-to-severe Alzheimer's disease (AD) who are not on memantine (Namenda)....
NEW YORK , Jan. 22, 2020 /PRNewswire/ -- Neurotrope, Inc. (Nasdaq: NTRP) ("Neurotrope" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, today announced its corporate update. The Company has completed analysis o...
Gainers: Synthorx (NASDAQ: THOR ) +170% . More news on: Synthorx, Inc., ArQule, Inc., Forty Seven, Inc., Stocks on the move, Read more ...
NEW YORK , Oct. 8, 2019 /PRNewswire/ -- Neurotrope, Inc. (Nasdaq: NTRP), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, today announced its plans to explore strategic alternatives to maximize shareholder value. "Following the re...
Oramed Pharmaceuticals (NASDAQ: ORMP ) initiated with Buy rating and $7 (136% upside) at Ladenburg Thalmann. Shares up 3% premarket. More news on: Oramed Pharmaceuticals Inc., PhaseBio Pharmaceuticals, Inc., Bicycle Therapeutics plc, Healthcare stocks news, Stocks on the move, ...
News, Short Squeeze, Breakout and More Instantly...
SUNRISE, FL / ACCESSWIRE / July 19, 2024 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip," "we," "our," or the "Company"), a travel technology company, received a notice (the "Notice") from the listing qualifications department of the Nasdaq Stock Market LLC ("Nasdaq") on July 17, 2024 stating the...
Dynamic Content-to-Commerce FAST Channel Reinvents Monetization Models SUNRISE, FL / ACCESSWIRE / July 18, 2024 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip," "we," "our," or the "Company"), a travel technology company, today announced that it has partnered with OTT ("over-the-top") services...
Allows Consumers to Pay for Accommodations Through Interest-free Installments with Convenient and Flexible Payment Options when Booking Travel Seamless Integration Enables Marketing Opportunities in Social Media Travel Package Campaigns and Direct-to-Consumer Marketing Channels to Drive Sale...